Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Net Income (2016 - 2025)

Historic Net Income for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $27.7 million.

  • Merit Medical Systems' Net Income fell 247.5% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.5 million, marking a year-over-year decrease of 359.05%. This contributed to the annual value of $105.5 million for FY2024, which is 2900.4% up from last year.
  • Per Merit Medical Systems' latest filing, its Net Income stood at $27.7 million for Q3 2025, which was down 247.5% from $32.6 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Net Income peaked at $35.7 million during Q2 2024, and registered a low of $4.9 million during Q2 2021.
  • Moreover, its 5-year median value for Net Income was $18.5 million (2022), whereas its average is $20.1 million.
  • As far as peak fluctuations go, Merit Medical Systems' Net Income surged by 54322.15% in 2021, and later crashed by 1907.33% in 2023.
  • Over the past 5 years, Merit Medical Systems' Net Income (Quarter) stood at $16.0 million in 2021, then rose by 15.83% to $18.5 million in 2022, then dropped by 19.07% to $15.0 million in 2023, then dropped by 12.76% to $13.1 million in 2024, then soared by 112.18% to $27.7 million in 2025.
  • Its Net Income was $27.7 million in Q3 2025, compared to $32.6 million in Q2 2025 and $30.1 million in Q1 2025.